EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review

Hiba Mikhael-Moussa, Valérie Bertrand, Emeline Lejeune, Claire Dupont, Alexandra Aupetit, Najate Achamrah, Chloé Melchior

Neurogastroenterology & Motility · 2025-09 · 37 (9)

DOI: 10.1111/nmo.70039 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 30.03.2025. Verfasst von Hiba Mikhael-Moussa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rouen Normandie, INSERM, Normandie Univ, ADEN UMR1073, Nutrition, Inflammation and Microbiota-Gut-Brain Axis, Rouen, France. Hauptthemen laut MEDLINE: Gastrointestinal Diseases, Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders, Brain-Gut Axis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with neurogastroenterology disorders like disorders of gut–brain interaction (DGBI) and gastrointestinal (GI) motility disorders often adopt restrictive diets to manage symptoms. Without professional guidance, these patients may risk developing avoidant/restrictive food intake disorder (ARFID), potentially affecting their physical and mental health.

Purpose

This scoping review aimed to explore the prevalence of ARFID in patients with neurogastroenterology disorders and vice versa, the direction of their association, potential risk factors, and available treatments.

Methods

Following PRISMA‐ScR guidelines, we searched PubMed, Web of Science, and Cochrane. Abstracts were screened for eligibility by two independent reviewers. Key Results Eighteen studies met our inclusion criteria. The prevalence of ARFID symptoms in neurogastroenterology patients ranged from 10% to 80%, while the prevalence of neurogastroenterology disorders and related GI symptoms in ARFID patients ranged from 7% to 60%. Findings on the direction of the association between eating difficulties and GI symptom occurrence were conflicting. Patients with ARFID‐neurogastroenterology disorder overlap were more likely to be female, have a lower BMI, higher anxiety and depression levels, and poorer quality of life. Two small studies evaluating treatment for this overlap suggested promising effects of cognitive behavioral therapy (CBT). Conclusions and Inferences This review highlights heterogeneity in study designs and questions the suitability of ARFID assessment tools in this context. It also underscores gaps in understanding the underlying pathophysiology and treatment approaches. Future research should prioritize validating ARFID screening tools specific to this population and standardizing study methodologies. Improved understanding of this overlap will help healthcare professionals improve management strategies and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal DiseasesAvoidant Restrictive Food Intake DisorderFeeding and Eating DisordersBrain-Gut AxisHumansPrevalence

Stichwörter der Autor:innen

ARFIDDGBIavoidant restrictive food intake disorderdisorders of gut–brain interactionneurogastroenterology

Autor:innen und Institutionen

  • Univ Rouen Normandie, INSERM, Normandie Univ, ADEN UMR1073, Nutrition, Inflammation and Microbiota-Gut-Brain Axis, Rouen, France.
  • Department of Pediatrics, Le Havre Hospital, Le Havre, France.
  • Department of Digital Health, Rouen University Hospital, Rouen, France.
  • Department of Pediatrics, Caen University Hospital, Caen, France.
  • Department of Gastroenterology, Rouen University Hospital, Rouen, France.
  • Department of Nutrition, Rouen University Hospital, Rouen, France.

Zitieren

APA

Mikhael-Moussa, H., Bertrand, V., Lejeune, E., Dupont, C., Aupetit, A., Achamrah, N., & Melchior, C. (2025). The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review. Neurogastroenterology & Motility, 37(9). https://doi.org/10.1111/nmo.70039

Vancouver

Mikhael-Moussa H, Bertrand V, Lejeune E, Dupont C, Aupetit A, Achamrah N, et al. The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review. Neurogastroenterology & Motility. 2025;37(9). doi:10.1111/nmo.70039

BibTeX
@article{MikhaelMoussa2025,
  author = {Mikhael-Moussa, Hiba and Bertrand, Valérie and Lejeune, Emeline and Dupont, Claire and Aupetit, Alexandra and Achamrah, Najate and Melchior, Chloé},
  title = {The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  volume = {37},
  number = {9},
  doi = {10.1111/nmo.70039}
}
Kostenlos starten →